Community-acquired pneumonia in elderly patients.
CAP in elderly patients carries a significant economic and clinical burden and will be more commonly encountered in the future as the US population ages. Diagnosis may be obscured by a nonclassic presentation in an elderly patient, and the clinician needs to be especially suspicious of pneumonia whenever the clinical status of an elderly patient deteriorates. The single most important clinical decision is the site of care; this determination is not always based on clinical factors but also on social factors. Severity assessment is key to stratifying appropriate therapy and to predicting outcome. Timely and appropriate empiric therapy enhances the likelihood of a good clinical outcome, although clinical resolution may be more delayed than in younger patients. Newly emerging patterns of antibiotic resistance have altered recent guidelines for CAP treatment; DRSP is now a consideration in elderly patients because an age older than 65 years is a well-described risk factor for infection with this organism. Prevention should always be implemented, with a focus on pneumococcal and influenza vaccination.
SUNY at Stony Brook, Stony Brook, NY, USA. mniederman@winthrop.org
Michael S
MS
Niederman
Qanta A A
QA
Ahmed
D000368:Aged; D017714:Community-Acquired Infections / Q000382:microbiology / Q000401:mortality / Q000628:therapy; D004352:Drug Resistance, Microbial; D006760:Hospitalization; D006801:Humans; D011008:Pneumococcal Infections / Q000453:epidemiology / Q000382:microbiology; D011014:Pneumonia; D011379:Prognosis; D012307:Risk Factors; D016896:Treatment Outcome